Brookstone Capital Management Acquires 2,187 Shares of McKesson Corporation $MCK

Brookstone Capital Management raised its holdings in shares of McKesson Corporation (NYSE:MCK) by 18.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 13,821 shares of the company’s stock after acquiring an additional 2,187 shares during the period. Brookstone Capital Management’s holdings in McKesson were worth $11,337,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. GGM Financials LLC bought a new stake in shares of McKesson during the 3rd quarter valued at $25,000. State of Wyoming bought a new position in McKesson in the 2nd quarter worth $29,000. Hopwood Financial Services Inc. purchased a new position in McKesson during the third quarter valued at $31,000. Vermillion & White Wealth Management Group LLC purchased a new position in McKesson during the third quarter valued at $33,000. Finally, Board of the Pension Protection Fund bought a new stake in McKesson during the fourth quarter valued at about $33,000. 85.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling at McKesson

In other news, Director Maria Martinez sold 349 shares of McKesson stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director owned 301 shares in the company, valued at $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on MCK shares. Morgan Stanley restated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Robert W. Baird set a $968.00 target price on shares of McKesson in a research note on Wednesday, January 14th. Finally, Raymond James Financial set a $970.00 price target on shares of McKesson in a report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $960.93.

McKesson Stock Up 0.6%

Shares of McKesson stock opened at $864.99 on Wednesday. The stock’s 50-day simple moving average is $908.89 and its 200-day simple moving average is $842.77. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The company has a market capitalization of $105.95 billion, a price-to-earnings ratio of 24.88, a PEG ratio of 1.38 and a beta of 0.38.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.